COVID-19 Risk Assessment for Automatic Diagnosis and Prognosis

A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Machine Learning and Artificial Intelligence in Diagnostics".

Deadline for manuscript submissions: closed (30 June 2022) | Viewed by 2698

Special Issue Editors


E-Mail Website
Guest Editor
Institute of Medical Biometry and Statistics, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany
Interests: statistical methods in hospital epidemiology; multistate modeling; mathematical modeling of epidemics

E-Mail Website
Guest Editor
BIOsignal Analysis for Rehabilitation and Therapy Research Group (BIOART), Universitat Politècnica de Catalunya, BarcelonaTech (UPC), Barcelona, Spain
Interests: biomedical signal processing; cognitive informatics in health and biomedicine; computer-assisted diagnosis and prognosis; medical data mining; neurological diagnostic techniques
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Priorities all over the world were changed by the ongoing coronavirus disease 2019 (COVID-2019) pandemic. Health systems thus face financial and facility challenges when managing this condition. Many studies reported the clinical characteristics and outcomes of COVID-19 patients, but few research studies focused on the risk assessment of outcomes [1–5]. Personal risk profiles can help physicians make the correct decision for optimal patient treatment.

Length of stay in the intensive care unit, duration of invasive ventilation, and the probability of death can describe the temporal dynamics of illness severity among hospitalized COVID-19 patients [6]. Statistical methods for analyzing time-dependent data could be applied for hospitalized COVID-19 patients [7]. “Fighting panic with information” [8] implies using proper statistical models to deduce the risk of bias [9,10]. The integration of proper biostatistical models and machine learning algorithms are helpful in health policymakers and risk assessment during current or future pandemics [11]. This Special Issue thus focuses on automatic COVID-19 diagnosis and prognosis, based on rigorous machine learning and biostatistical models, except mechanisms of pathogenesis, which are not within the scope of the Special Issue.

It is necessary to use STARD [12] (or) TRIPOD [13] guidelines (https://www.equator-network.org/) for diagnostic/prognostic studies, to ensure that the submitted papers have the acceptable quality.

Prof. Dr. Martin Wolkewitz
Prof. Dr. Hamid Reza Marateb
Guest Editors

References:

  1. Das AK, Mishra S, Saraswathy Gopalan S. Predicting CoVID-19 community mortality risk using machine learning and development of an online prognostic tool. PeerJ. 2020;8:e10083.
  2. Marateb HR, von Cube M, Sami R, Haghjooy Javanmard S, Mansourian M, Amra B et al. Absolute mortality risk assessment of COVID-19 patients: the Khorshid COVID Cohort (KCC) study. BMC Medical Research Methodology. 2021;21(1):146.
  3. Kar S, Chawla R, Haranath SP, Ramasubban S, Ramakrishnan N, Vaishya R et al. Multivariable mortality risk prediction using machine learning for COVID-19 patients at admission (AICOVID). Scientific Reports. 2021;11(1):12801.
  4. Heldt FS, Vizcaychipi MP, Peacock S, Cinelli M, McLachlan L, Andreotti F et al. Early risk assessment for COVID-19 patients from emergency department data using machine learning. Scientific Reports. 2021;11(1):4200.
  5. Yan L, Zhang H-T, Goncalves J, Xiao Y, Wang M, Guo Y et al. An interpretable mortality prediction model for COVID-19 patients. Nature Machine Intelligence. 2020;2(5):283-8.
  6. Hazard D, Kaier K, von Cube M, Grodd M, Bugiera L, Lambert J et al. Joint analysis of duration of ventilation, length of intensive care, and mortality of COVID-19 patients: a multistate approach. BMC Medical Research Methodology. 2020;20(1):206.
  7. Beyersmann J, Wolkewitz M, Allignol A, Grambauer N, Schumacher M. Application of multistate models in hospital epidemiology: Advances and challenges. Biometrical Journal. 2011;53(2):332-50.
  8. The Lancet. COVID-19: fighting panic with information. Lancet (London, England). 2020;395(10224):537.
  9. Wolkewitz M, Puljak L. Methodological challenges of analysing COVID-19 data during the pandemic. BMC Medical Research Methodology. 2020;20(1):81.
  10. Marateb HR, Mohebbian MR, Shirzadi M, Mirshamsi A, Zamani S, Abrisham chi A et al. Reliability of machine learning methods for diagnosis and prognosis during the COVID-19 pandemic: a comprehensive critical review. 2021. In: High Performance Computing for Intelligent Medical Systems [Internet]. IOP Publishing; [5-1-5-25]. Available from: http://0-dx-doi-org.brum.beds.ac.uk/10.1088/978-0-7503-3815-8ch5.
  11. Mansourian M, Marateb HR, Cube Mv, Khademi S, Jordanic M, Mananas MA et al. Reliable Diagnosis and Prognosis of COVID-19. In: Bajaj V, Sinha G, editors. Computer-aided Design and Diagnosis Methods for Biomedical Applications: CRC Press; 2021.
  12. Cohen JF, Korevaar DA, Altman DG, Bruns DE, Gatsonis CA, Hooft L et al. STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration. BMJ Open. 2016;6(11):e012799.
  13. Collins GS, Reitsma JB, Altman DG, Moons KGM. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD Statement. BMC Medicine. 2015;13(1):1.

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • machine learning
  • multi-state models
  • risk assessment models
  • survival analysis

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

13 pages, 1167 KiB  
Article
Systemic Inflammatory Predictors of In-Hospital Mortality in COVID-19 Patients: A Retrospective Study
by Bartosz Kudlinski, Dominika Zgoła, Marta Stolińska, Magdalena Murkos, Jagoda Kania, Pawel Nowak, Anna Noga, Magdalena Wojciech, Gabriel Zaborniak and Agnieszka Zembron-Lacny
Diagnostics 2022, 12(4), 859; https://0-doi-org.brum.beds.ac.uk/10.3390/diagnostics12040859 - 30 Mar 2022
Cited by 14 | Viewed by 2167
Abstract
The purpose of this study was to investigate whether routine blood tests and clinical characteristics can predict in-hospital mortality in COVID-19. Clinical data of 285 patients aged 59.7 ± 10.3 yrs. (males n = 189, females n = 96) were retrospectively collected from [...] Read more.
The purpose of this study was to investigate whether routine blood tests and clinical characteristics can predict in-hospital mortality in COVID-19. Clinical data of 285 patients aged 59.7 ± 10.3 yrs. (males n = 189, females n = 96) were retrospectively collected from December 2020 to June 2021. Routine blood tests were recorded within the 1st hour of admission to hospital. The inflammatory variables, such as C-reactive protein (CRP), procalcitonin (PCT), neutrophils–lymphocyte ratio (NLR) and the systemic inflammatory index (SII), exceeded the reference values in all patients and were significantly higher in deceased patients (n = 108) compared to survivors (n = 177). The log-rank test for comparing two survival curves showed that patients aged ≥60.5 years, with PCT ≥ 0.188 ng/mL or NLR ≥ 11.57 103/µL were at a greater risk of death. NLR demonstrated a high impact on the COVID-19 mortality (HR 1.317; 95%CI 1.004–1.728; p < 0.05), whereas CRP and SII showed no effect (HR 1.000; 95%CI 1.000–1.004; p = 0.085 and HR 1.078; 95%CI 0.865–1.344; p = 0.503, respectively). In the first Polish study including COVID-19 patients, we demonstrated that age in relation to simple parameters derived from complete blood cell count has prognostic implications in the course of COVID-19 and can identify the patients at a higher risk of in-hospital mortality. Full article
(This article belongs to the Special Issue COVID-19 Risk Assessment for Automatic Diagnosis and Prognosis)
Show Figures

Figure 1

Back to TopTop